IASO Biotherapeutics Stock

IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.

Sign up today and learn more about IASO Biotherapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About IASO Biotherapeutics Stock

IASO Biotherapeutics (IASO BIO) is a Nanjing-based biopharmaceutical company focused on the discovery, development and commercialization of cell therapies in the field of oncology.

Funding History

March 2020$60.0M
September 2021$108M
January 2023$500M

Management

CEO & CMO

Wen Wang

Co-Founder & Executive Vice President

Brian K. Hall

Chief Technology Officer and Executive Vice President

David HE

Chief Scientific Officer

Biao Zheng

Chief Financial Officer (CFO)

Alan Fu

Founder

Xuefei Huang

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo